Е.I. Alexeeva

1.8k total citations
93 papers, 322 citations indexed

About

Е.I. Alexeeva is a scholar working on Hematology, Speech and Hearing and Rheumatology. According to data from OpenAlex, Е.I. Alexeeva has authored 93 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Hematology, 44 papers in Speech and Hearing and 18 papers in Rheumatology. Recurrent topics in Е.I. Alexeeva's work include Autoimmune and Inflammatory Disorders Research (57 papers), Adolescent and Pediatric Healthcare (44 papers) and Immunodeficiency and Autoimmune Disorders (14 papers). Е.I. Alexeeva is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (57 papers), Adolescent and Pediatric Healthcare (44 papers) and Immunodeficiency and Autoimmune Disorders (14 papers). Е.I. Alexeeva collaborates with scholars based in Russia, United States and Italy. Е.I. Alexeeva's co-authors include Е. G. Chistyakova, И. П. Никишина, Vyacheslav Chasnyk, Nicolino Ruperto, Gerd Horneff, Pierre Quartier, Hermine I. Brunner, Xiaoling Wei, Baranov Aa and Kenneth Abrams and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Annals of the Rheumatic Diseases.

In The Last Decade

Е.I. Alexeeva

62 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Е.I. Alexeeva Russia 9 213 124 79 74 60 93 322
María Martha Katsicas Argentina 10 204 1.0× 110 0.9× 80 1.0× 56 0.8× 66 1.1× 24 334
Elena Palmisani Italy 11 318 1.5× 140 1.1× 83 1.1× 71 1.0× 124 2.1× 37 451
Sheila Oliveira United States 6 165 0.8× 80 0.6× 67 0.8× 75 1.0× 70 1.2× 7 298
Vyacheslav Chasnyk Russia 10 173 0.8× 73 0.6× 61 0.8× 61 0.8× 48 0.8× 73 315
Tomohiro Kubota Japan 10 239 1.1× 92 0.7× 61 0.8× 119 1.6× 113 1.9× 29 384
Adele Civino Italy 8 176 0.8× 103 0.8× 52 0.7× 49 0.7× 41 0.7× 25 299
Anton Hospach Germany 13 316 1.5× 165 1.3× 126 1.6× 101 1.4× 91 1.5× 36 452
Polly Livermore United Kingdom 7 145 0.7× 88 0.7× 63 0.8× 52 0.7× 58 1.0× 25 255
Ximena Norambuena Chile 7 189 0.9× 102 0.8× 103 1.3× 29 0.4× 46 0.8× 15 276
Frank Weller‐Heinemann Germany 12 325 1.5× 175 1.4× 111 1.4× 94 1.3× 126 2.1× 37 460

Countries citing papers authored by Е.I. Alexeeva

Since Specialization
Citations

This map shows the geographic impact of Е.I. Alexeeva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Е.I. Alexeeva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Е.I. Alexeeva more than expected).

Fields of papers citing papers by Е.I. Alexeeva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Е.I. Alexeeva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Е.I. Alexeeva. The network helps show where Е.I. Alexeeva may publish in the future.

Co-authorship network of co-authors of Е.I. Alexeeva

This figure shows the co-authorship network connecting the top 25 collaborators of Е.I. Alexeeva. A scholar is included among the top collaborators of Е.I. Alexeeva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Е.I. Alexeeva. Е.I. Alexeeva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Авдеев, С. Н., Vladimir Chulanov, Е.I. Alexeeva, et al.. (2023). The burden of COVID-19 in a heterogeneous population of immunocompromised patients – realities of the postpandemic. Terapevticheskii arkhiv. 95(8). 722–729. 1 indexed citations
3.
Alexeeva, Е.I., et al.. (2023). Safety and efficacy of canakinumab treatment for undifferentiated autoinflammatory diseases: the data of a retrospective cohort two-centered study. Frontiers in Medicine. 10. 1257045–1257045. 6 indexed citations
4.
5.
Roock, Sytze de, Gabriella Giancane, Е.I. Alexeeva, et al.. (2022). Prevalence of familial autoimmune diseases in juvenile idiopathic arthritis: results from the international Pharmachild registry. Pediatric Rheumatology. 20(1). 103–103. 5 indexed citations
6.
Ward, Leanne M., Nathalie Alos, David A. Cabral, et al.. (2021). Zoledronic Acid vs Placebo in Pediatric Glucocorticoid-Induced Osteoporosis: A Randomized, Double-Blind, Phase 3 Trial. The Journal of Clinical Endocrinology & Metabolism. 106(12). e5222–e5235. 26 indexed citations
7.
Fisenko, Аndrey P., et al.. (2021). SITUATION OF CHILDREN WITH DISABILITIES IN CONTEMPORARY LEGAL, MEDICAL AND SOCIAL PROCESSES IN THE RUSSIAN FEDERATION. PEDIATRIA Journal named after G N SPERANSKY. 100(4). 198–207. 3 indexed citations
8.
Quartier, Pierre, Е.I. Alexeeva, Tamás Constantin, et al.. (2020). Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open‐Label, Randomized Study. Arthritis & Rheumatology. 73(2). 336–346. 23 indexed citations
9.
Alexeeva, Е.I., et al.. (2017). THE EXPERIENCE OF SWITCHING TO THE SECOND TNF INHIBITOR IN A PATIENT WITH SEVERE JUVENILE POLYARTHRITIS AND RESISTANCE TO THE FIRST TNF-BLOCKER. Вопросы современной педиатрии. 16(4). 314–320.
10.
Alexeeva, Е.I., et al.. (2014). ASSESSMENT OF THE QUALITY OF LIFE OF PATIENTS WITH THE JUVENILE IDIOPATHIC ARTHRITIS TREATED BY THE ETANERCEPT. Вопросы современной педиатрии. 13(4). 26–26. 1 indexed citations
11.
Alexeeva, Е.I., et al.. (2013). Retrospective Analysis of Efficacy and Safety of Tocilizumab Treatment in Children with Severe Systemic Juvenile Idiopathic Arthritis: 12-month Follow-up. SHILAP Revista de lepidopterología. 12(2). 26–26. 2 indexed citations
12.
Namazova-Baranova, Leyla S., et al.. (2012). TREATMENT WITH AMINO-ACID-BASED FORMULA OF CHILDREN WITH ALIMENTARY ALLERGY TO COW MILK PROTEINS. SHILAP Revista de lepidopterología. 11(3). 65–65. 1 indexed citations
13.
Alexeeva, Е.I., et al.. (2012). ANTI-CD20 MONOCLONAL ANTIBODIES IN TREATMENT OF HAEMOLYTIC ANEMIA IN A TEENAGE GIRL WITH SYSTEMIC LUPUS ERYTHEMATOSUS. SHILAP Revista de lepidopterología. 11(6). 147–147. 1 indexed citations
14.
15.
Alexeeva, Е.I., et al.. (2010). NEW OPPORTUNITIES IN TREATMENT OF JUVENILE ANKYLOSING SPONDYLOARTHRITIS. SHILAP Revista de lepidopterología.
16.
Alexeeva, Е.I., et al.. (2010). ALGORITHM OF DIAGNOSTICS AND TREATMENT OF JUVENILE ARTHRITIS. SHILAP Revista de lepidopterología. 1 indexed citations
17.
Alexeeva, Е.I., et al.. (2010). EXPERIENCE OF TREATMENT WITH IBANDRONIC ACID IN PATIENTS WITH SEVERE RHEUMATOLOGICAL DISEASES AND SYSTEMIC OSTEOPOROSIS. SHILAP Revista de lepidopterología. 1 indexed citations
18.
Alexeeva, Е.I., et al.. (2009). RELIABILITY, VALIDITY AND SENSITIVITY OF RUSSIAN VERSIONS OF PEDSQL GENERIC CORE SCALE AND PEDSQL RHEUMATOLOGY MODULE QUESTIONNAIRES. SHILAP Revista de lepidopterología. 3 indexed citations
19.
Alexeeva, Е.I., et al.. (2008). PSYCHOMETRICAL CHARACTERISTICS OF RUSSIAN VERSIONS OF PEDSQL RHEUMATOLOGY MODULE AND PEDSQL GENERIC CORE SCALE QUESTIONNAIRES FOR THE ESTIMATION OF QUALITY OF LIFE OF CHILDREN AGED FROM 2 TO 4 YEARS OLD WITH JUVENILE RHEUMATOID ARTHRITIS. SHILAP Revista de lepidopterología.
20.
Alexeeva, Е.I., et al.. (2006). USE OF MYCOPHENOLATE MOPHETYL IN PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS. SHILAP Revista de lepidopterología. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María Martha Katsicas Breakdown of academic impact, for papers by Elena Palmisani Breakdown of academic impact, for papers by Sheila Oliveira Breakdown of academic impact, for papers by Vyacheslav Chasnyk Breakdown of academic impact, for papers by Tomohiro Kubota Breakdown of academic impact, for papers by Adele Civino Breakdown of academic impact, for papers by Anton Hospach Breakdown of academic impact, for papers by Polly Livermore Breakdown of academic impact, for papers by Ximena Norambuena Breakdown of academic impact, for papers by Frank Weller‐Heinemann
Rankless by CCL
2026